oral allosteric glucokinase activator
Ph. III candidate in T2DM
HbA1c reduction vs placebo
Nat. Med.
Hua Medicine, Shanghai, CN
Dorzagliatin
Context. Dorzagliatin (Hua Medicine) is an oral dual-acting full glucokinase (GK) activator being developed for type 2 diabetes. More than 50 years since the first report of the role…